Flowr Corp
XTSX:FLWR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Flowr Corp
Cash & Cash Equivalents
Flowr Corp
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Flowr Corp
XTSX:FLWR
|
Cash & Cash Equivalents
CA$4.2m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Cash & Cash Equivalents
$1.3B
|
CAGR 3-Years
36%
|
CAGR 5-Years
14%
|
CAGR 10-Years
0%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Cash & Cash Equivalents
CA$371.3m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
34%
|
|
|
Cronos Group Inc
TSX:CRON
|
Cash & Cash Equivalents
$791.8m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
99%
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Cash & Cash Equivalents
$20m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Cash & Cash Equivalents
CA$76.4m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-11%
|
|
Flowr Corp
Glance View
The Flowr Corp. engages in the production and sale of premium cannabis. The company is headquartered in Toronto, Ontario and currently employs 186 full-time employees. The company went IPO on 2017-09-15. The principal activity of the Company is the production and sale of cannabis in Canada, and medical cannabis products in other legal global markets, primarily Portugal and the European Union. The firm operates in Flowr Canada segment. Flowr Canada segment is a licensed producer operating in Canada. The firm is focused on producing cannabis products for medical patients and recreational consumers across Canada, utilizing its indoor and outdoor cultivation and processing facilities located in the city of Kelowna in the Okanagan Valley Region of British Columbia, Canada (the Kelowna Campus). The Company’s brands include Flowr and FlowrRX. Flowr is a brand of cannabis produced in the Okanagan Valley.
See Also
What is Flowr Corp's Cash & Cash Equivalents?
Cash & Cash Equivalents
4.2m
CAD
Based on the financial report for Dec 31, 2021, Flowr Corp's Cash & Cash Equivalents amounts to 4.2m CAD.
What is Flowr Corp's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
30%
Over the last year, the Cash & Cash Equivalents growth was -80%. The average annual Cash & Cash Equivalents growth rates for Flowr Corp have been -47% over the past three years , 30% over the past five years .
